Future of Cancer Health Economics Research Conference

Cancer, in addition to impacts on morbidity, mortality, and quality of life, has substantial economic consequences. The medical care costs for cancer in the U.S. were $183 billion in 2015 and are projected to increase to $246 billion in 2030. Other cancer-related costs across the care continuum may be less well understood. Additional information is needed on factors affecting patient, health care system, and societal costs for cancer prevention, screening, treatment, and survivorship. However, multiple factors may limit cancer health economics research.

The Division of Cancer Control and Population Science (DCCPS) of the National Cancer Institute (NCI) is interested in learning more about gaps and unmet needs for performing health economics research focused on cancer; barriers and challenges to conducting cancer health economics research; and potential activities to support and enhance this field. As part of HEROiC, the Interagency Consortium to Promote Health Economics Research on Cancer (https://healthcaredelivery.cancer.gov/heroic/), and in collaboration with scientists at the Centers for Disease Control and Prevention (CDC) and the American Cancer Society, DCCPS will sponsor a conference on The Future of Cancer Health Economics Research on Dec. 2 and 3, 2020. This conference will include presentations on challenges conducting cancer health economics research and broad, participatory discussions on activities help support and enhance the development of this field. The conference will be free, open to the public, and will include livestreaming options. Conference presentations will be recorded and available to the public for later viewing.

Last Updated
September 24, 2020